Preface

Authors:
  • SASharon R Akabas
    Sharon R Akabas
  • RDRichard J Deckelbaum
    Richard J Deckelbaum

Abstract
Despite the known and varied health benefits of n−3 fatty acids, current US intakes are lower than national (1-6) and international (7) recommendations, and considerable confusion exists about safe and biologically active sources of n−3 fatty acids. Confusion also exists about how the dietary recommendations for these nutrients are set; in particular, it is not clear whether n−3 fatty acids are best obtained from sources containing preformed eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It is also not clear how intakes of n–6 and n−3 fatty acid precursors affect the interconversion to biologically active forms.